Numerous studies have shown a connection between increased OPN secretion and many other cancers, including glioblastoma, breast and prostate cancer, squamous cell carcinoma, melanoma, and OS. In lung cancer, overexpression of OPN is linked to both patient survival and the results of therapeutic interventions like surgery, chemotherapy, or radiotherapy. Here, SPP1 is linked to lung cancer.